Gad Dotan - research works

Despite treatment with three intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections, the CNV demonstrated limited response and progressive enlargement, leading to poor final visual outcome.

Overall, six consecutive patients (2 males, mean age 19.5 ± 9.74 years) were identified and studied.

Most common eye injuries included corneal erosion (n=4), traumatic hyphema (n=4), and retinal edema (n=3).

Mean initial logMAR visual acuity in the injured eye was 0.73 ± 0.18, improving to 0.25 ± 0.16 at the final visit (P = 0.125).

Two patients underwent eye surgery due to their trauma: one to repair globe penetration and another to undergo intravitreal injection of tissue plasminogen activator and C3F8 for submacular hemorrhage, followed 8 months later by intravitreal bevacizumab injection for choroidal neovascularization.

The study group included 20 adult patients (9 men, 11 women, mean age 57.2 years) with ASD who had undergone successful closure with the Amplatzer occluder.

The patients were treated with aspirin or warfarin during 6 months after the procedure.

Ocular examination included the 120-point Humphrey visual field.

Two patients complained of amaurosis fugax at 1 and 3 months after the procedure, and two patients complained of blurred vision at 3 and 4 months after the procedure.